Does Dr. JONATHAN CHOW have financial conflicts of interest?

Dr. JONATHAN CHOW (M.D.) has received a total of $216,194 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $216,194 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. JONATHAN CHOW?

According to CMS Open Payments data, Dr. JONATHAN CHOW received funding from LA JOLLA PHARMACEUTICAL COMPANY ($131,996), EXTHERA MEDICAL CORPORATION ($67,719), and HEMOSONICS ($16,316).

Does Dr. JONATHAN CHOW receive research grants or speaking fees?

Dr. JONATHAN CHOW has received $216,194 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. JONATHAN CHOW

M.D.Real-Time Hydrated

Specialty: Anesthesiology, Critical Care Medicine

Practice Location: WASHINGTON, DC 20037

NPI Number: 1275809261

LIFETIME INDUSTRY VALUE

$216,194

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. CHOW is a verified Anesthesiology, Critical Care Medicine practitioner based in WASHINGTON, DC.

Between 2021 and 2024, Dr. CHOW had an overall industry promotional and research financial footprint of $216,194 as recorded in the federal CMS Open Payments database.

$216,194 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. CHOW's primary funding source is LA JOLLA PHARMACEUTICAL COMPANY, which accounts for $131,996 (representing 61.1% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

LA JOLLA PHARMACEUTICAL COMPANY

Rank 1

$131,996

61.1%

EXTHERA MEDICAL CORPORATION

Rank 2

$67,719

31.3%

HEMOSONICS

Rank 3

$16,316

7.5%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.